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Abstract 
 
The retinal ganglion cells (RGCs) from porcine eyes were extracted to work towards a 
potential therapy for glaucoma. There is not a known cause of glaucoma or the apoptosis of 
RGCs that cause the eventual blindness associated with glaucoma. The goal of this protocol 
is to protect the RGCs from dying by adding a nicotinic acetylcholine receptor activator to 
induce neuronal proliferation and protect against glutamate-induced excitotoxicity. PNU 
282987 was used as the nicotinic acetylcholine receptor activator due to its neuroprotective 
properties. We hypothesized that we would observe the proliferation of RGCs (associated 
with increased cell numbers) with varying levels of PNU 282987 compared to a set of 
untreated control plates. For each protocol three plates labelled A were left untreated, three 
plates labelled B were treated with 40 μL of PNU 282987 (100 μM), and three plates 
labelled C were treated with 80 μL of PNU 282987 (200 μM). We analyzed pictures of the 
plates using Image J. The average cell count and average area were analyzed for our 
purposes to check for the proliferation of RGCs and determine the size of the cells that 
survived and replicated. Although there seemed to be an increased average cell count in 
plates B compared to plates A and C and an increase in average area in plates C compared to 
plates A and B, our data did not have statistical significance. Further experiments will have 
to be conducted to determine if PNU 282987 significantly induces the proliferation of 
RGCs, and if its neuroprotective properties can be used as a potential treatment for 
glaucoma or provide further insight into the cause of this disease. 
 
Introduction 
 
Glaucoma is an ocular neurodegenerative disease that is caused by the death of retinal 
ganglion cells (RGCs) and their axons which eventually leads to blindness.1–6 RGCs interact 
indirectly with the photoreceptors that receive the light that enters the eye. RGCs, whose 
axons form the optic nerve, transmits the image to our brain to be interpreted. These RGCs 
die via apoptosis presumably due to glutamate-induced excitotoxicity.3–7 Müller glia cells 
usually are responsible for protecting neurons such as RGCs against glutamate-induced 
excitotoxicity by clearing glutamate.8,9 Many have believed that an increase in intraocular 
pressure (IOP) is a cause of glaucoma, yet there are patients with normotensive (normal IOP) 
glaucoma. But there seems to be strong correlation between a high IOP and the degeneration 
of RGCs. If one already has glaucoma, an increased IOP has been correlated with faster 
development of glaucoma.2 An elevated IOP has been shown to be followed by a decrease in 
mitochondria in the optic nerve.10,11 It can be unsafe to alter a patient’s blood pressure in 
order to attempt to lower the IOP2, so other treatment options for glaucoma such as directly 
addressing the death of RGCs may be a safer and more effective option for patients.   
Large RGCs seem to be targeted especially during apoptosis, but RGCs of all sizes are 
affected by this disease.5 The death of the axons negatively affects vision due to the loss of 
transportation of substances between the cell body and axon terminal. This could cause the 
RGCs to die due to an intracellular electrolyte imbalance or microglial phagocytosis.12  
RGC regeneration has been seen in other organisms, for example the zebrafish.13,14 Once 
the RGCs have sustained damage, Müller glia are induced to dedifferentiate into multipotent 
neural progenitor cells.8,9 These cells move to the damaged region of the retina and 
differentiate into the cell type that was damaged.14 Due to the successful regeneration of 
retinal cells in other organisms, we believe that this line of research can be extended to 
mammalian retinas, specifically porcine retinas. It has been shown that insulin growth factor 
inhibitors can halt the proliferation of certain tissues.14 In order to combat this, we enrich the 
second media with insulin, transferrin and nerve-growth factor. Importantly, a recent study 
has shown that Müller glia are involved in the proliferation of RGCs in rodent retinas in 
response to alpha7 nicotinic acetylcholine receptors (nAChR) agonists.15,16  
Mammalian nervous systems have an abundance of nicotinic receptors for 
acetylcholine.17 For this protocol, we focused on targeting the nAChR found near the optic 
nerve because there is evidence to show that these receptors are neuroprotective.1,3,4,6,18 But, 
a recent study in a rodent model of glaucoma, provided evidence for the role of retinal 
pigment epithelium (RPE) of responding to such compounds and inducing proliferation from 
Müller glia.15,16 Most research on glaucoma has focused on the issue of IOP within the eye. 
IOP is not always a consistent indicator of glaucoma or its severity, and even if the IOP is 
treated, oftentimes RGCs continue to die.19 To get to the root of the problem of this disease, 
we have attempted to induce proliferation of RGCs in a mixed retinal cell culture using PNU 
282987. PNU 282987 has been shown to have neuroprotective properties on isolated RGCs3, 
so we hypothesize that PNU 282987 will protect existing RGCs and possibly cause a 
proliferation of RGCs in culture and an increase in average size and numbers due to mitosis 
taking place.  
 
Methods 
 
Sterile Technique 
The timeline for the experiment is shown in Figure 1. The porcine eyes were obtained 
from DeVries Meats in Coopersville, MI. The sterile technique begins by wiping down the 
hood with ~40% ethanol solution. Then place the 1000 μL pipette and pipette tips; the 200 
μL pipette and pipette tips; small plastic autoclaved vials; a white-capped glass vial; 
Parafilm; scissors; tape; Kimwipes; Sharpie; automatic pipette and two disposable plastic  
 
pipette tips; autoclaved glass pipette tips and pipette bulb; Fischer plates; 100 mL beaker; 
dissecting scissors; scalpel, and forceps in the hood. Turn the UV light and the blower on 
with the hood slightly open for 20 minutes. Be sure to wear gloves and sterilize the gloves 
with ethanol each time you enter the hood.  
 
Figure 1: Experimental 
Timeline. On the first day of 
the protocol, one must 
sterilize the hood, clean the 
eyes by removing the flesh 
around the eye and ocular 
nerve, dissect the eyes, plate 
the cells and incubate the 
plates for 48 hours. After the 
48 hours, take pictures of 
each of the plates.  
Preparing the Eyes 
Remove the DNase, insulin (10 mg/mL), transferrin (500 µg/mL) and nerve growth 
factor from the freezer to thaw. Label two 50 mL plastic centrifuge tubes Media #1 and 
Media #2. Fill Media #1 with 33 mL and Media #2 with 36 mL of CO2-Independent 
Medium. Add 3.5 mL of pig ringers solution to the white capped glass vial. Combine 87.5 μL 
of papain with 210 μL of papain activating solution in a small autoclaved plastic vial. 
Incubate the vial while dissecting. Dissect 6 retinas per protocol. First, remove the flesh 
around each eye using the dissecting scissors while at the lab bench. Place the eyes in a 100 
mL beaker with ice. Move to the hood for the remainder of the dissection. Turn off the UV 
light and blower when dissecting.  
 
Dissection 
Use a Fischer plate to dissect the eyes, the bottom with the taller lip for dissecting, and 
the top for isolating the RGCs once they have been extracted. To dissect an eye, take the 
scalpel and make an incision about eight centimeters away from the iris. Gently push the eye 
up against the lip of the dish for stability. Be sure to not place too much pressure on the eye. 
Once the incision has been made, take the forceps and grasp the eye and use the dissecting 
scissors to continue the incision around the iris until the anterior and posterior parts of the 
eye are separated. Now take another set of forceps in place of the dissecting scissors and use 
these to remove the thin layer of opaque RGCs from the back of the eye. Avoid extracting the 
black retinal pigmented epithelium (RPE) with the RGCs. Place the RGCs in the adjacent 
dish, and using the scalpel, chop up the RGCs. Transfer the RGCs to the white capped glass 
vial. Clean the dishes with ethanol and wipe with Kimwipes. Repeat this process for the 
remaining eyes.  
Add the vial of papain and papain activating solution to the white caped vial and incubate 
for 20 minutes at 37°C, shaking every 7 minutes. During incubation, label nine Fischer plates            
using the Sharpie: A1, A2, A3, B1, B2, B3, C1, C2, and C3 as shown in Figure 2. Write 
initials and date of the experiment on each plate with the number one on it. Enrich Media #2 
with 75 μL of nerve growth factor, 72 μL of transferrin, and 18 μL of insulin using a 200 μL 
pipette.  
 
Figure 2: Fischer Plate Setup. The 
plates were labelled A1-C3. The 
plates labelled A received no PNU 
282987 and were used as a control. 
The plates labelled B were given 40 
μL of PNU 282987. The plates 
labelled C were given 80 μL of PNU 
282987.  
Plating and Incubation 
After incubation, return to the hood with the white capped glass vial and add 100 μL of 
DNase. Let sit for one minute. Take the glass pipette tip and begin to transfer the retina 
mixture from the white-capped glass vial to the Media #1 tube. As you go, filter blood 
vessels and black RPE cells out on to a paper towel. Once the filtered retina mixture has been 
added to Media #1, shake Media #1 well, and using the automatic pipette to add 3 mL of the 
mixture to each of the nine Fischer plates that are labelled. Be sure that the bottom of the 
plates are coated evenly. Place them in the incubator at 37°C for one hour. Remove all excess 
equipment from the hood except for the automatic pipette, Kimwipes, parafilm, 200 μL 
pipette and pipette tips. Place the vacuum flask, its attachments, a glass pipette tip and a 
clean 100 mL beaker inside the hood. Turn on the UV light and the blower on with the hood 
slightly open to disinfect the hood. Remove the PNU 282987 from the fridge to thaw.  
Remove the plates after one hour and return them to the hood. Use the vacuum to remove 
the media from the plates. Fill the 100 mL with a small amount of ethanol. Dip the tip of the 
pipette in ethanol. Gently tip each plate on an angle and touching the tip of the pipette to the 
wall of the plate, not the bottom. Between each plate, dip the pipette in ethanol to disinfect. 
Add 4 mL of Media #2 to each Fischer plate. Be sure that the bottom of the plates are coated 
evenly as before.  
The plates labelled A are the control. Add nothing to them. Add 40 μL of the PNU 
282987 to the B plates. Add 80 μL of the PNU 282987 to the C plates. Cover the plates and 
place them in the incubator for 48 hours at 37°C.  
 
Imaging 
Remove the plates from the incubator. Use the Nikon Eclipse E400 to image the cells. 
Use the DAPI setting and the 10x magnification on the microscope. Wait for the cells to 
settle and stop moving before you capture an image. Take one picture of each plate and label 
them as they are labelled on the Fischer plates, A1-C3. Save them separately to a flash drive 
for analysis. Use Image J to analyze the images of the plates. We used Image J to count the 
cells and determine their average size in μm2. 
 
 
Results 
 
The two variables measured from the images taken were the average number of cells in 
the picture of each plate and the average area of the cells. Examples of these images from 
each plate are shown below in Figure 3. The cells were counted using a threshold technique 
to contrast from the background.  
 
The A plates, the control, had an average of 1908.4 cells per picture with a standard error 
of the mean of 447.125. The B plates, treated with 40 μL of PNU, had an average of 
2280.095 cells per picture with a standard error of the mean of 639.98. The C plates, treated 
with 80 μL of PNU, had an average of 1844.95 cells per picture with a standard error of the 
mean 623.367. These values are shown in Figure 4. There appears to be an increase in cell 
numbers in the B plates compared to the A plates and C plates.  
 
 
Figure 4: Average Cell Count. 
The A plates (control) had an 
average of 1908.4 cells per 
picture with a standard error of 
the mean (SEM) of 447.125. The 
B plates (40 μL of PNU 282987) 
had an average of 2280.095 cells 
per picture with an SEM of 
639.98. The C plates (80 μL of 
PNU 282987) had an average of 
1844.95 cells per picture and an 
SEM of 623.367. 
Figure 3: Pictures of Plates A, B and C. (A) This is a sample of an image taken of an A plate. The 
cells are shown against the beige background. (B) This shows an example of an image of the cells 
found on a B plate. (C) This image shows the cells found on a C plate.  
 The C plates had the largest average area of a cell of 362,552 μm2 with a standard error of 
the mean of 158,887.7. Plates A and B have similar average area. The average area of the A 
plates is 191,241.8 μm2 with a standard error of the mean of 120,262. The average area of the B 
plates is 181,194.9 μm2 with a standard error of the mean of 115,988.4. These values can be seen 
in Figure 5. Although the B plates appear to have the largest average area of its cells when 
comparing the three plates, there was no statistical significance with this data set, so we cannot 
say that there is a difference among the three variables.  
 
 
  
 
Discussion 
 
The described protocol was run seven times. We compared the average cell count 
between the plates to determine if mitosis had occurred since there should be more cells if 
proliferation had occurred. A cellular count that is significantly higher or lower in any of the 
plates would tell us if PNU 282987 was effective at stimulating mitosis in RGCs. Although it 
appeared that the B plates treated with 40 μL (100 μM) of PNU 282987 did have an increase 
in the cell count, Figure 3 shows that the cumulative data surrounding cell count was 
statistically insignificant. We may have seen an increase in cell count in only the B plates 
because 80 μL (200 μM) of PNU 282987 may have surpassed the saturation point of the 
RGCs rendering the excess PNU detrimental to the RGCs. Or, the higher dose was not the 
optimal dose to see an effect after the time we cultured our cells. 100 µM was found to be 
most effective over a comparable time frame when examining isolated RGCs in culture.20 
We compared the average cell size because a change in cell size could be considered as 
potential proof of cells going through replication and thus mitotic division. The average 
Figure 5: Average Area. The 
average area that the cells take 
up in the pictures of the A 
plates is 191,241.8 μm2 with a 
SEM of 120,262. The average 
area that the cells take up in 
the pictures of the B plates is 
181,194.9 μm2 with a SEM of 
115,988.4. The average area 
that the cells take up in the 
pictures of plates C is 362,552 
μm2 with a SEM of 158,887.7.  
diameter of a RGC is between 7 and 21.5 μm21 making the range of the average area of a 
RGC between 153.94 μm2 and 1452.2 μm2. However, it appears in Figure 4 that the C plates 
(200 μM) had the largest cells according to the average area of 362,552 μm2. This could 
indicate that mitosis was indeed occurring in the RGCs since the cells were larger compared 
to the A and B plates as well as the average area of RGCs. The average cell size found on the 
C plates (200 μM) were almost twice as large as the RGCs on the control plates. Although 
the average area we observed for the control plates, 191,241.8 μm2, does not fit within the 
expected range of the average area of an RGC, we would expect that the proper amount of 
PNU 282987 would double the size of those cells due to the replication of those existing 
cells.   
 Even though the C plates had a lower average cell count as shown in Figure 3, that could 
have occurred because the cells that were amid replication had not divided yet. However, 
since this data was also statistically insignificant, more data would have to be collected to 
support this hypothesis. Conversely, one might expect the average cell size to be smaller after 
this relatively short incubation time since it would take time for cells to grow to full size. 
 
Limitations 
Human error needs to be considered a limitation during data collection. There are four 
students in the lab, and not all the protocols were done by the same student. For everyone to 
get experience using the microscope, the pictures were taken by different people within the 
lab. If the number of data sets had been larger, this too would have given us more accurate 
data since an increased sample size reduces random error. Due to time constraints and 
technical issues, only seven protocols were able to be completed for this paper.  
When the plates were filled, the Media #1 was shaken, then promptly filled the plates 
starting with plate A1 every time. Even though the media was shaken prior to each plate 
being filled, we cannot guarantee that an equal amount of RGCs were distributed among the 
nine plates. My hypothesis is that since the A plates were filled first, they received the most 
RGCs. Even if there were proliferation in the plates labelled B and C, if all plates did not 
start out with close to equal number of cells, then we cannot be sure that proliferation took 
place or if the PNU 282987 was effective in any way. In future protocols I would suggest that 
we start by filling plates B or C and then rotate to eliminate or diminish this confounding 
variable. However, this was explored with isolated RGCs, and with enough shaking, no 
significant difference was found using different plating routines. But one cannot rule out that 
this mixed retinal cell system would be different. 
Only one picture was taken of each plate and that could lead to an inaccurate 
representation of the total amount of cells on each plate. The visual field of the microscope 
could not cover the entire area of the plate, so we cannot be sure that the pictures taken of the 
plates were an accurate representation of the cell counts on each plate. To diminish the effect 
of this confounding variable, next time I would take multiple pictures of each plate. I would 
take at least four pictures of each plate by turning the plate ninety degrees for each picture 
taken. This is the usual protocol for the isolated RGC culture system, with images captured at 
‘north, south, east and west’. 
Since the cells were plated in a liquid media, they did not have the chance to adhere to 
the bottom of the plate; they were suspended in the liquid. This allowed the cells to move 
about freely when the plates were moved. This could have posed problems in the following 
ways. When replacing Media #1 with the enriched Media #2, cells could have been removed 
due to the vacuum. This could have resulted in a lower cell count in certain plates. When 
imaging, the cells had to take time to settle and stop their movement within the media. We 
had no control over the distribution of the cells in the plates. This could have resulted in the 
images not accurately representing the typical concentration of cells throughout the entire 
plate. However, with isolated RGC cultures, it was observed that cells that adhered to the 
surface were more viable and floating cells were usually dead or dying. 
  Moving forward, we would check the circularity of the cells to ensure that we are 
observing RGCs. A rating of 1 means that the cell is perfectly circular, and as the rating 
approaches zero, the cell become more elliptical.22 This would function as a confirmation of 
the specific cell type we have been observing. We would also increase the magnification of 
the Nikon Eclipse E400 by one degree of magnification, to the 40x magnification, in order to 
improve our counting of the cells and better analyze why some cells are larger than others, 
for example if some cells are proceeding through mitosis or not. These are issues with this 
relatively new mixed culture system and should benefit future experiments. 
 
 
 Conclusion 
 
  From the protocols run, we were unable to statistically determine if PNU 282987 was 
successful in targeting the alpha7 nicotinic acetylcholine receptors and activating their 
neuroprotective and proliferative properties. Due to the appearance of the data, we believe 
that there is the potential for PNU 282987 to be preventative in the progression of glaucoma 
as an effective activator of the nicotinic acetylcholine receptor and protector of RGCs. The 
appropriate amount of PNU 282987 has yet to be determined to reflect results observed in 
live rodents with experimentally induced glaucoma.15 The lab will continue to pursue 
potential treatments for glaucoma by focusing on the direct causes of blindness such as the 
death of RGCs rather than other symptoms such as increased IOP.  
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